FDA advisors say changes are need to reprocessing methods used by most hospitals for duodenoscopes, but that the devices involved in contamination incidents should stay on the market for life-saving endoscopic retrograde cholangiopancreatograpy (ERCP) procedures.
A majority of the FDA Gastroenterology-Urology Devices panel – about two-thirds – called for enhanced cleaning of the duodenoscopes, followed...